The Simcyp’s Population-based Simulator, combined with our suite of software products and scientific consulting services has provided significant drug development advantages to our clients. The Simcyp Simulator includes extensive demographic, physiologic and genomic databases which include algorithms which account for patient variability. This enables the user to predict drug behavior in virtual patient populations instead of a virtual reference man, allowing individuals at extreme risk to be identified.
The Simcyp Simulator
Streamlines drug development through the modeling and simulation of PK/PD in virtual populations.
Publications & Resources
Review research results in conference abstracts & peer-reviewed papers.
Providing hands-on data analysis, data interpretation, report writing & guidance in regulatory submissions.
The Consortium acts as a steering committee to ensure new products & services are relevant to the needs of the industry.
Workshops & Trainings
Programs & hands-on workshops on various aspects of model-based drug development are available.
Questions? Contact Us
If you have a question regarding Simcyp’s products or services learn how you can contact us to learn more.